Market Value1,499,047,038
Total Holdings70
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TECH / Bio-Techne Corporation
AFMD / Affimed N.V.
TARO / Taro Pharmaceutical Industries Ltd.
TSVT / 2seventy bio, Inc.
TSHA / Taysha Gene Therapies, Inc.
KRYS / Krystal Biotech, Inc.
SWAV / Shockwave Medical, Inc.
IMVT / Immunovant, Inc.
THC / Tenet Healthcare Corporation
AVTE / Aerovate Therapeutics, Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
ILMN / Illumina, Inc.
GOSS / Gossamer Bio, Inc.
STRO / Sutro Biopharma, Inc.
LQDA / Liquidia Corporation
VERA / Vera Therapeutics, Inc.
NTRA / Natera, Inc.
ELV / Elevance Health, Inc.
CYH / Community Health Systems, Inc.
HQY / HealthEquity, Inc.
CNC / Centene Corporation
UTHR / United Therapeutics Corporation
HCA / HCA Healthcare, Inc.
PBYI / Puma Biotechnology, Inc.
HUM / Humana Inc.
RGEN / Repligen Corporation
BCRX / BioCryst Pharmaceuticals, Inc.
PFE / Pfizer Inc.
CVAC / CureVac N.V.
MRUS / Merus N.V.
NAMS / NewAmsterdam Pharma Company N.V.
ZIMV / ZimVie Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
SPY / SPDR S&P 500 ETF Put
CRBP / Corbus Pharmaceuticals Holdings, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
MNKD / MannKind Corporation
AFMD / Affimed N.V.
IMGN / ImmunoGen, Inc.
BHVN / Biohaven Ltd.
VKTX / Viking Therapeutics, Inc.
A / Agilent Technologies, Inc.
WAT / Waters Corporation
VTRS / Viatris Inc.
KPTI / Karyopharm Therapeutics Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
LLY / Eli Lilly and Company
MOH / Molina Healthcare, Inc.
RVTY / Revvity, Inc.
IQV / IQVIA Holdings Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
VINC / Vincerx Pharma, Inc.
TERN / Terns Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc.
XOMA / XOMA Royalty Corporation
DHR / Danaher Corporation
IFRX / InflaRx N.V.
INSP / Inspire Medical Systems, Inc.
PTGX / Protagonist Therapeutics, Inc.
ALEC / Alector, Inc.
VRDN / Viridian Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
ICLR / ICON Public Limited Company
BKD / Brookdale Senior Living Inc.
AVTR / Avantor, Inc.
STOK / Stoke Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
NVRO / Nevro Corp.
GH / Guardant Health, Inc.
ACIU / AC Immune SA
GSK / GSK plc - Depositary Receipt (Common Stock)
MCRB / Seres Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.